… In the studied groups, we performed therapeutic management oriented towards managing …
optimal therapeutic option in the pneumothorax COVID-19 group. In the non-COVID-19 group, …

… (ISTH) Guidelines on antithrombotic management of COVID‐19, several topics were identified
… in the antithrombotic management of coronavirus disease 2019 (COVID‐19) patients and …

… therapeutic approach for COVID-19 encephalopathy is quite similar to the approach in
non-COVID … However, we feel that there are management points to emphasize in the COVID-19 …

… as therapeutic agents against COVID‑19, or in the prevention of infection. The present review
highlights the prevalent clinical manifestations of COVID‑19, … ‑CoV‑2 therapeutic agents. In …

… COVID-19. We also discuss the clinical importance of recent immune biomarkers in COVID-19,
and at the end of each section, recent clinical trials in immune biomarkers for COVID-19 …

… D and its possible involvement in management of COVID-19. … therapies for the management
of COVID-19; hence, non-… for the mitigation of COVID-19. Recent research suggests that …

… of antithrombotic therapy (… , therapy) are guided by the clinical context and the COVID-19
severity. We provide a practical approach on antithrombotic therapy management for COVID-19 …

… patients affected by COVID-19. Hereby, we show our recommendations for the management
of COVID-19 patients, based … In particular, patients who could benefit from TCZ therapy are: …

… Interest in corticosteroid therapy in COVID-19 has been … of COVID-19. We sought to conduct
a systematic review on the role of corticosteroid in the management of patients of COVID-19. …

… In addition, some patients with COVID-19 require renal replacement therapy (RRT). According
to the results of this review study, AKI is consistently associated with increased mortality in …